What a fat-headed load of steaming codswallop.
By all means, join the dots on former directors, their relationships and networks that may lead to the first clinical evaluation of ALA's technology.
Casting aspersions on former directors with an infintessimally small holding, is fallacious in the extreme.
Ann: Investor Presentation Imugene Arovella Therapies, page-6
Add ALA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.5¢ |
Change
0.005(2.63%) |
Mkt cap ! $205.1M | |||
| Open | High | Low | Value | Volume |
| 19.0¢ | 20.5¢ | 18.8¢ | $291.0K | 1.504M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 133485 | 19.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.5¢ | 70700 | 5 |
View Market Depth
| Last trade - 14.55pm 17/10/2024 (20 minute delay) ? |
| ALA (ASX) Chart |